[ad_1]
Photo: Reference
( Caracas, July 12. News24 ) .- Treatment with Ribociclib, an innovative drug that has just arrived in Latin America, helps to increase survival in patients with metastatic breast cancer and improve the quality of life of women who suffer from it
"About 60 or 70% of women with breast cancer will have a subtype of cancer associated with endocrine therapy or presenting positive hormone receptors.This led to the development of new therapies, "said Dr. Gabriela Regalado in an interview with Efe.
Overall, this disease kills more than eight millions of people each year and at least 90% of cancer deaths are caused by metastases, that is, when cancer cells invade other organs.
" Currently, the treatment is con u for women who develop metastatic disease. They may be premenopausal women, or postmenopausal women in combination with another treatment, and this (new) drug has shown substantial improvement, "said the specialist in internal medicine and oncology at the ABC Medical Center
according to the specialized treatment control the disease to the point of serving women who may be in the metastatic stage with disseminated disease or even, in those who die, to help them to have better results.
D & # 39, after information provided by EFE
Views of Publication:
1.078
[ad_2]
Source link
